SynthesisFrontiers in surgery2024

Mirabegron 50 mg once daily, long-term treatment maximizes benefit in middle-aged and older people with overactive bladder syndrome: a systematic review and meta-analysis of nine phase II/III, randomized, double-blind, parallel-design, placebo-controlled, multicenter, and multinational trials.

Xiangxiang Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.